Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 3417643, 12 pages
https://doi.org/10.1155/2018/3417643
Research Article

Cost Saving Potential of an Early Detection of Atrial Fibrillation in Patients after ICD Implantation

1Institute for Social Medicine, Epidemiology and Health Economics, Charite-Universitätsmedizin Berlin, Luisenstrasse 57, 10117 Berlin, Germany
2Biotronik, Woermannkehre 1, 12359 Berlin, Germany
3German Heart Centre Munich, Department of Electrophysiology, Faculty of Medicine, Technische Universität München, Munich, Germany

Correspondence should be addressed to Thomas Reinhold; ed.etirahc@dlohnier.samoht

Received 4 January 2018; Revised 28 June 2018; Accepted 11 July 2018; Published 14 August 2018

Academic Editor: Natale Daniele Brunetti

Copyright © 2018 Thomas Reinhold et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. AQUA - Institut für Angewandte Qualitätsförderung und Forschung im Gesundheitswesen. Bundesauswertung zum Erfassungsjahr 2012: 09/4 – Implantierbare Defibrillatoren - Implantation - Qualitätsindikatoren: 2013.
  2. S. G. Priori, C. Blomström-Lundqvist, A. Mazzanti et al., “2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC),” European Heart Journal, vol. 36, no. 41, pp. 2793–2867, 2015. View at Google Scholar
  3. J. S. Healey, S. J. Connolly, M. R. Gold et al., “Subclinical atrial fibrillation and the risk of stroke,” The New England Journal of Medicine, vol. 366, no. 2, pp. 120–129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. T. V. Glotzer, E. G. Daoud, D. G. Wyse et al., “The Relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study,” Circulation: Arrhythmia and Electrophysiology, vol. 2, no. 5, pp. 474–480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Boriani, T. V. Glotzer, M. Santini et al., “Device-detected atrial fibrillation and risk for stroke: An analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices),” European Heart Journal, vol. 35, no. 8, pp. 508–516, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Strickberger, J. Ip, S. Saksena, K. Curry, T. D. Bahnson, and P. D. Ziegler, “Relationship between atrial tachyarrhythmias and symptoms,” Heart Rhythm, vol. 2, no. 2, pp. 125–131, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. G. Hart, L. A. Pearce, and M. I. Aguilar, “Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation,” Annals of Internal Medicine, vol. 146, no. 12, pp. 857–867, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Kirchhof, S. Benussi, D. Kotecha et al., “2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organisation (ESO),” European Heart Journal, vol. 37, no. 38, pp. 2893–2962, 2016. View at Google Scholar
  9. A. E. DeCicco, J. B. Finkel, A. J. Greenspon, and D. R. Frisch, “Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices,” Heart Rhythm, vol. 11, no. 4, pp. 719–724, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Niehaus, A. Schuchert, S. Thamasett et al., “Multicenter experiences with a single lead electrode for dual chamber ICD systems,” Pacing and Clinical Electrophysiology, vol. 24, no. 10, pp. 1489–1493, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Schuchert, M. Niehaus, L. Binner, R. Belke, and T. Meinertz, “Feasibility of atrial sensing via a free-floating single-pass defibrillation lead for dual-chamber defibrillators,” Journal of Interventional Cardiac Electrophysiology, vol. 8, no. 3, pp. 209–214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Safak, D. Schmitz, T. Konorza, C. Wende, J. O. De Ros, and A. Schirdewan, “Clinical efficacy and safety of an implantable cardioverter-defibrillator lead with a floating atrial sensing dipole,” Pacing and Clinical Electrophysiology, vol. 36, no. 8, pp. 952–962, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Varma, A. E. Epstein, A. Irimpen, R. Schweikert, and C. Love, “Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: The lumos-t safely reduces routine office device follow-up (TRUST) trial,” Circulation, vol. 122, no. 4, pp. 325–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Seidl, E. Meisel, E. Vanagt et al., “Is the atrial high rate episode diagnostic feature reliable in detecting paroxysmal episodes of atrial tachyarrhythmias?” Pacing and Clinical Electrophysiology, vol. 21, no. 4 I, pp. 694–700, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Sticherling, D. Mueller, B. Schaer, D. Baensch, and C. Kolb, “Safety and diagnostic accuracy of a cardiac resynchronization therapy-defibrillator with a floating atrial bipole in heart failure patients with permanent atrial fibrillation,” Ehra Europace-Cardiostim, vol. 1380, p. 1380, 2015. View at Google Scholar
  16. U. Schwabe, “Arzneiverordnungen 2011 im Überblick,” in Arzneiverordnungsreport 2015, U. Schwabe and D. Paffrath, Eds., Springer, Berlin, Germany, 2012. View at Google Scholar
  17. D. Bänsch, H. Bonnemeier, J. Brandt et al., “Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: The NORDIC ICD randomized clinical trial,” European Heart Journal, vol. 36, no. 37, pp. 2500–2507, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. A. J. Camm, G. Accetta, G. Ambrosio et al., “Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation,” Heart, vol. 103, no. 4, pp. 307–314, 2017. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Y. H. Lip and G. D. O. Lowe, “Antithrombotic treatment for atrial fibrillation,” British Medical Journal, vol. 312, no. 7022, pp. 45–49, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. M. R. Patel, K. W. Mahaffey, J. Garg et al., “Rivaroxaban versus warfarin in nonvalvular atrial fibrillation,” The New England Journal of Medicine, vol. 365, no. 10, pp. 883–891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Pieri, T. O. Lopes, and A. A. Gabbai, “Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation,” International Journal of Stroke, vol. 6, no. 5, pp. 466–466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Go, E. M. Hylek, Y. Chang et al., “Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation: How Well Do Randomized Trials Translate into Clinical Practice?” Journal of the American Medical Association, vol. 290, no. 20, pp. 2685–2692, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. Camm, P. Kirchhof, G. Y. Lip, U. Schotten, I. Savelieva, S. Ernst et al., “Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC),” Europace, vol. 12, no. 10, pp. 1360–1420, 2010. View at Google Scholar
  24. T. J. Bunch, J. D. Day, B. Olshansky, K. Q. Stolen, and C. M. Mullin, “Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality,” Heart Rhythm, vol. 6, no. 1, pp. 2–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Mittal, K. Stein, F. R. Gilliam III, S. M. Kraus, T. E. Meyer, and S. A. Christman, “Frequency, Duration, and Predictors of Newly-Diagnosed Atrial Fibrillation Following Dual-Chamber Pacemaker Implantation in Patients Without a Previous History of Atrial Fibrillation,” American Journal of Cardiology, vol. 102, no. 4, pp. 450–453, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. P. A. Friedman, R. L. McClelland, W. R. Bamlet et al., “Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: The detect supraventricular tachycardia study,” Circulation, vol. 113, no. 25, pp. 2871–2879, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Moss, C. Schuger, C. A. Beck et al., “Reduction in inappropriate therapy and mortality through ICD programming,” The New England Journal of Medicine, vol. 367, no. 24, pp. 2275–2283, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. E. I. Charitos, U. Stierle, P. D. Ziegler et al., “A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: Insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions,” Circulation, vol. 126, no. 7, pp. 806–814, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. P. A. Wolf, R. D. Abbott, and W. B. Kannel, “Atrial fibrillation as an independent risk factor for stroke: the Framingham study,” Stroke, vol. 22, no. 8, pp. 983–988, 1991. View at Publisher · View at Google Scholar · View at Scopus
  30. H. J. Lin, P. A. Wolf, M. Kelly-Hayes et al., “Stroke severity in atrial fibrillation: the framingham study,” Stroke, vol. 27, no. 10, pp. 1760–1764, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. G. H. Van Welsenes, J. B. Van Rees, C. J. W. Borleffs et al., “Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients,” Europace, vol. 13, no. 3, pp. 389–394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Stewart, C. L. Hart, D. J. Hole, and J. J. V. McMurray, “A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study,” American Journal of Medicine, vol. 113, no. 5, pp. 359–364, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Brüggenjürgen, K. Rossnagel, S. Roll et al., “The impact of atrial fibrillation on the cost of stroke: The Berlin Acute Stroke Study,” Value in Health, vol. 10, no. 2, pp. 137–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Bufe, S. Frey, and S. Briswalter, “Durch Blutungen verursachte Kosten bei der Therapie des akuten Koronarsyndroms in Deutschland,” Herz, vol. 34, no. 6, pp. 479–484, 2009. View at Publisher · View at Google Scholar
  35. P. L. Kolominsky-Rabas, P. U. Heuschmann, D. Marschall et al., “Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry—The Erlangen Stroke Project,” Stroke, vol. 37, no. 5, pp. 1179–1183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Briggs, M. Sculpher, and M. Buxton, “Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis,” Health Economics, vol. 3, no. 2, pp. 95–104, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. D. S. Ice, T. A. Shapiro, E. M. Gnall, and P. R. Kowey, “Unanswered questions in patients with concurrent atrial fibrillation and acute coronary syndrome,” American Journal of Cardiology, vol. 113, no. 5, pp. 888–896, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. T. S. Tischer, R. Schneider, J. Lauschke et al., “Prevalence of atrial fibrillation in patients with high CHADS2- and CHA2DS2VASc-scores: Anticoagulate or monitor high-risk patients?” Pacing and Clinical Electrophysiology, vol. 37, no. 12, pp. 1651–1657, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. A.-M. Sinha, C. Stellbrink, A. Schuchert et al., “Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator,” Journal of Cardiovascular Electrophysiology, vol. 15, no. 6, pp. 646–652, 2004. View at Publisher · View at Google Scholar · View at Scopus